Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
MA05 - Improving Outcomes in Locoregional NSCLC II
- 13:30 - 15:00
- 9/24/2018
- Location: Room 105
- Type: Mini Oral Abstract Session
- Track: Treatment of Locoregional Disease - NSCLC
-
+
MA05.01 - E6508: Phase II Study of Immunotherapy with Tecemotide and Bevacizumab after Chemoradiation in Unresectable Stage III NS-NSCLC
13:30 - 13:35 | Presenter: Jyoti Patel | Author(s): Ju-Whei Lee, Henry Wagner Jr, David P Carbone, Anil Shanker, Leora Horn, Melissa L. Johnson, David E Gerber, Jane Jijun Liu, Millie S Das, Mohammad Ali Al-Nsour, Christopher S R Dakhil, Suresh S. Ramalingam, Joan Schiller
- Abstract
Loading...
-
+
OA05 - Clinical Trials in IO
- 13:30 - 15:00
- 9/24/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Advanced NSCLC
-
+
OA05.01 - Efficacy/Safety of Entinostat (ENT) and Pembrolizumab (PEMBRO) in NSCLC Patients Previously Treated with Anti-PD-(L)1 Therapy
13:30 - 13:40 | Presenter: Matthew D. Hellmann | Author(s): Pasi A Jänne, Mateusz Opyrchal, Navid Hafez, Luis E Raez, Dmitry Gabrilovich, Fang Wang, Peter Ordentlich, Susan Brouwer, Serap Sankoh, Emmett Schmidt, Michael L Meyers, Suresh S. Ramalingam
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-112 - Osimertinib vs Standard of Care (SoC) EGFR-TKI as First-Line Treatment in Chinese Patients With EGFRm Advanced NSCLC
16:45 - 18:00 | Presenter: Caicun Zhou | Author(s): Ying Cheng, Yong He, Wei Li, Helong Zhang, Qing Zhou, Buhai Wang, Chunling Liu, Suresh S. Ramalingam, Andrew Walding, Matilde Saggese, Jia Wang, Minhao Fan, Yi-Long Wu
- Abstract
Loading... -
+
P1.01-88 - Osimertinib Maintenance After Definitive Chemoradiation in Patients with Unresectable EGFRm-Positive Stage III NSCLC (LAURA)
16:45 - 18:00 | Presenter: Lu Shun | Author(s): Tony Nash, Matilde Saggese, Helen Mann, Suresh S. Ramalingam
- Abstract
Loading...
-
+
P1.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.16-47 - Adjuvant Targeted Therapy Following Standard Adjuvant Therapy for Resected NSCLC: An Initial Report from ALCHEMIST (Alliance A151216)
16:45 - 18:00 | Presenter: Geoffrey R. Oxnard | Author(s): Sumithra Mandrekar, Shauna Hillman, Angelina Tan, Ramaswamy Govindan, Dennis Wigle, Shakun Malik, Colleen Watt, David E Gerber, Jamie E Chaft, Suzanne Dahlberg, Karen Kelly, Meredith Faggen, Philip Stella, Karim Tazi, David R. Gandara, Suresh S. Ramalingam, Thomas E. Stinchcombe
- Abstract
Loading...
-
+
MA15 - Colliding Approaches - EGFR and Immunotherapy
- 13:30 - 15:00
- 9/25/2018
- Location: Room 107
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
-
+
MA15.03 - PD-L1 Expression in Untreated EGFRm Advanced NSCLC and Response to Osimertinib and SoC EGFR-TKIs in the FLAURA Trial
13:40 - 13:45 | Presenter: Suresh S. Ramalingam | Author(s): Helen Brown, Johan F. Vansteenkiste, Kazuhiko Nakagawa, Manuel Cobo Dols, Thomas John, Craig Barker, Alexander Kohlmann, Alexander Todd, Matilde Saggese, Juliann Chmielecki, Aleksandra Markovets
- Abstract
Loading...
-
+
MA18 - Modelling, Decision-Making and Population-Based Outcomes
- 13:30 - 15:00
- 9/25/2018
- Location: Room 201 F
- Type: Mini Oral Abstract Session
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
-
+
MA18.10 - Evolving Immunotherapy Practice Patterns in Advanced NSCLC: Analysis of an Online Treatment Decision Tool
14:30 - 14:35 | Presenter: David R. Gandara | Author(s): Timothy A Quill, Martin J. Edelman, Suresh S. Ramalingam, Heather A Wakelee, Howard West, Kevin L Obholz
- Abstract
Loading...
-
+
PC07 - The Future of Cytotoxic Chemotherapy in Advanced NSCLC
- 13:30 - 15:00
- 9/25/2018
- Location: Room 202 BD
- Type: Pro-Con Session
- Track: Advanced NSCLC
-
+
PC07.01 - Debate 2: Chemotherapy Will Become a Thing of the Past in the Management of Advanced NSCLC - For
14:10 - 14:30 | Presenter: Suresh S. Ramalingam
- Abstract
No abstract available for this presentation
-
+
P3.12 - Small Cell Lung Cancer/NET (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.12-06 - SLFN11 Expression and Efficacy of PARP Inhibitor Therapy in Extensive Stage Small Cell Lung Cancer: ECOG-ACRIN 2511 Study
12:00 - 13:30 | Presenter: Taofeek Owonikoko | Author(s): Suzanne Dahlberg, Gabriel L Sica, John Poirier, Lauren Byers, Charles M. Rudin, Ignacio I. Wistuba, Suresh S. Ramalingam
- Abstract
Loading...